7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2 Purity >99.0% (HPLC) Afatinib Dimaleate Intermediate Factory

Short Description:

Name: 7-Chloro-6-Nitro-4-Hydroxyquinazoline

CAS: 53449-14-2

Purity: >99.0% (HPLC) 

Appearance: Light Yellow to Light Brown Powder

Intermediate of Afatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name 7-Chloro-6-Nitro-4-Hydroxyquinazoline 
Synonyms 7-Chloro-4-Hydroxy-6-Nitroquinazoline; 7-Chloro-6-Nitro-4-Quinazolinol; 7-Chloro-6-Nitro-4-Quinazolinone; 7-Chloro-6-Nitro-4(3H)-Quinazolinone; 7-Chloro-6-Nitro-3,4-Dihydroquinazolin-4-one; 7-Chloro-6-Nitroquinazolin-4(3H)-one
CAS Number 53449-14-2
CAT Number RF-PI2030
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C8H4ClN3O3
Molecular Weight 225.59
Sensitivity Heat Sensitive
Solubility Slightly Soluble in Dimethylformamide
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Light Yellow to Light Brown Powder
Identification (HPLC) Retention Time of Sample Should Matches with Standard
Purity / Analysis Method >99.0% (HPLC)  
Melting Point 300.0~303.0℃
Water Content (K.F) <0.50%
Residue on Ignition <0.30%
Impurity 1 <0.50% (7-Chloro-4-Hydroxyquinazoline CAS: 31374-18-2)
Impurity 2 <0.50% (5,7-Dichloro-4[1H]quinazolinone)
Impurity 3 <1.00% (7-Chloro-8-Nitro-4[1H]quinazolinone)
Other Single Impurity <0.20%
Total Impurities <1.00%
Heavy Metals (as Pb) <20ppm
Infrared Spectrum  Conforms to Structure
Proton NMR Spectrum Proton NMR Spectrum
Test Standard Enterprise Standard
Usage Intermediate of Afatinib, Afatinib Dimaleate

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

1

FAQ:

Application:

7-Chloro-6-Nitro-4-Hydroxyquinazoline (CAS: 53449-14-2) is an intermediate of Afatinib Dimaleate (CAS: 850140-73-7). Afatinib is an irreversible ErbB family of blockers that suppress information transmission and block the major pathways involved in cancer cell growth and division.  Because ErbB family information transduction mechanism can be triggered by multiple homodimers and heterodimers, simultaneous inhibition of multiple ErbB family members (such as EGFR, HER2, ErbB3 and ErbB4) can effectively interrupt the downstream information transduction. Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer) that has spread to other parts of the body. It belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal receptor-EGFR) in some tumors.

  • Write your message here and send it to us